Xeris Pharmaceuticals Provides a Business Update During Recent Investor Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: XERS) | Delayed: 10.29 -0.57 (5.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.86 | 52 Week High | $ | |||
| Open | $10.85 | 52 Week Low | $ | |||
| Day High | $10.85 | P/E | N/A | |||
| Day Low | $10.19 | EPS | $ | |||
| Volume | 1,030,245 | |||||
| (NASDAQ: XERS) | Delayed: 10.29 -0.57 (5.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.86 | 52 Week High | $ | |||
| Open | $10.85 | 52 Week Low | $ | |||
| Day High | $10.85 | P/E | N/A | |||
| Day Low | $10.19 | EPS | $ | |||
| Volume | 1,030,245 | |||||
